Compare Novartis AG (NVS) vs Zoom Video Communications, Inc. (ZM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Zoom Video Communications, Inc. — how do they compare? Novartis AG trades at $153.03 (market cap $295.37B), while Zoom Video Communications, Inc. trades at $103.58 (market cap $31.10B). The key difference: Novartis AG is far larger — about 9.5× Zoom Video Communications, Inc.'s market cap, and Novartis AG pays a 3.07% dividend while Zoom Video Communications, Inc. pays none. Which is the better fit depends on your goals.
| NVS | ZM | |
|---|---|---|
Market Cap | $295.37B | $31.10B |
Sector | Health | Technology |
52-Week High | $168.62 | $111.88 |
52-Week Low | $119.31 | $69.96 |
Enterprise Value | $336.69B | $23.44B |
Dividend Yield | 3.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis AG (NVS) trades at $156.79, up 0.29% today, with a bullish technical signal from moving averages and recent Q2 2026 earnings beating estimates. Strong profitability is evident with a 74.74% gross margin and 22.5% net margin, while revenue grew to $56.67B in 2025. The stock faces resistance near $157, with support at $156.
The outlook is positive due to robust drug pipeline progress and reaffirmed 2026 guidance, though risks include generic competition for Entresto and pricing pressures. Analyst sentiment is mixed with 24% buy ratings, but institutional buying activity supports confidence in long-term growth.
Zoom Communications (ZM) trades at $107.20, up 2.58% today, with a bullish technical signal from moving averages and a consensus analyst price target of $118.79. The stock shows strong profitability with a net income margin of 41.99% and ROE of 21.95%, supported by recent earnings beats. However, insider selling and mixed oscillators suggest caution amid overbought conditions.
Outlook: ZM offers growth potential with solid fundamentals and AI-driven product expansions, but risks include competitive pressures and volatile cash flows. Investors should weigh the high valuation (P/E 15.62) against earnings consistency and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Zoom Video Communications, Inc.
Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.
Read more on ZM →
